Rhythm Pharmaceuticals Inc
NASDAQ:RYTM

Watchlist Manager
Rhythm Pharmaceuticals Inc Logo
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
Watchlist
Price: 59.18 USD -5.1% Market Closed
Market Cap: 3.8B USD

Wall Street
Price Targets

RYTM Price Targets Summary
Rhythm Pharmaceuticals Inc

Wall Street analysts forecast RYTM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RYTM is 80.84 USD with a low forecast of 65.65 USD and a high forecast of 98.7 USD.

Lowest
Price Target
65.65 USD
11% Upside
Average
Price Target
80.84 USD
37% Upside
Highest
Price Target
98.7 USD
67% Upside
Rhythm Pharmaceuticals Inc Competitors:
Price Targets
NYKD
Nykode Therapeutics ASA
183% Upside
LTRN
Lantern Pharma Inc.
674% Upside
BMRN
Biomarin Pharmaceutical Inc
69% Upside
688235
Beigene Ltd
18% Upside
TGTX
TG Therapeutics Inc
23% Upside
ELDN
Eledon Pharmaceuticals Inc
237% Upside
688373
Shanghai MicuRx Pharmaceutical Co Ltd
8% Downside
CDNA
CareDx Inc
66% Upside

Revenue
Forecast

Revenue Estimate
Rhythm Pharmaceuticals Inc

The compound annual growth rate of Rhythm Pharmaceuticals Inc's revenue for the next 3 years is 60%.

N/A
Past Growth
60%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Rhythm Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Rhythm Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-35%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RYTM's stock price target?
Price Target
80.84 USD

According to Wall Street analysts, the average 1-year price target for RYTM is 80.84 USD with a low forecast of 65.65 USD and a high forecast of 98.7 USD.

What is Rhythm Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
60%

The compound annual growth rate of Rhythm Pharmaceuticals Inc's revenue for the next 3 years is 60%.

Back to Top